Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis

Pam Molenaar; Daniala Weir; Edo P. J. Arnoldus; Martijn Beenakker; Robert van den Bos; Paul Bouma; Jeroen van Eijk; Carola Feenstra; Bjorn van Geel; Thea Heersema; E. Hoitsma; Katalin Horvath; Joep Killestein; Jolijn Kragt; Caspar van Munster; Angelique Snoeijen; Beatrijs Wokke; Wim Goettsch; Eva Strijbis; Janet de Beukelaar; Nynke. F. Kalkers; de Jong Brigit

Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis

Pam Molenaar
, Daniala Weir
, Edo P. J. Arnoldus
, Martijn Beenakker
, Robert van den Bos
, Paul Bouma
, Jeroen van Eijk
, Carola Feenstra
, Bjorn van Geel
, Thea Heersema
, E. Hoitsma
, Katalin Horvath
, Joep Killestein
, Jolijn Kragt
, Caspar van Munster
, Angelique Snoeijen
, Beatrijs Wokke
, Wim Goettsch
, Eva Strijbis
, Janet de Beukelaar

Nynke. F. Kalkers, de Jong Brigit

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	359-360
Number of pages	2
Journal	Multiple Sclerosis Journal
Volume	31
Issue number	S3
Publication status	Published - Sept 2025
Event	41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - Barcelona, Spain Duration: 24 Sept 2025 → 26 Sept 2025

Cite this

Molenaar, P., Weir, D., Arnoldus, E. P. J., Beenakker, M., van den Bos, R., Bouma, P., van Eijk, J., Feenstra, C., van Geel, B., Heersema, T., Hoitsma, E., Horvath, K., Killestein, J., Kragt, J., van Munster, C., Snoeijen, A., Wokke, B., Goettsch, W., Strijbis, E., ... Brigit, D. J. (2025). Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis. Multiple Sclerosis Journal, 31(S3), 359-360.

@article{1b903e34cc0a4e59970047f1b740a2b4,

title = "Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis",

author = "Pam Molenaar and Daniala Weir and Arnoldus, \{Edo P. J.\} and Martijn Beenakker and \{van den Bos\}, Robert and Paul Bouma and \{van Eijk\}, Jeroen and Carola Feenstra and \{van Geel\}, Bjorn and Thea Heersema and E. Hoitsma and Katalin Horvath and Joep Killestein and Jolijn Kragt and \{van Munster\}, Caspar and Angelique Snoeijen and Beatrijs Wokke and Wim Goettsch and Eva Strijbis and \{de Beukelaar\}, Janet and Kalkers, \{Nynke. F.\} and Brigit, \{de Jong\}",

year = "2025",

month = sep,

language = "English",

volume = "31",

pages = "359--360",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE",

number = "S3",

note = "41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) ; Conference date: 24-09-2025 Through 26-09-2025",

}

Molenaar, P, Weir, D, Arnoldus, EPJ, Beenakker, M, van den Bos, R, Bouma, P, van Eijk, J, Feenstra, C, van Geel, B, Heersema, T, Hoitsma, E, Horvath, K, Killestein, J, Kragt, J, van Munster, C, Snoeijen, A, Wokke, B, Goettsch, W, Strijbis, E, de Beukelaar, J, Kalkers, NF & Brigit, DJ 2025, 'Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis', Multiple Sclerosis Journal, vol. 31, no. S3, pp. 359-360.

Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis. / Molenaar, Pam; Weir, Daniala; Arnoldus, Edo P. J. et al.
In: Multiple Sclerosis Journal, Vol. 31, No. S3, 09.2025, p. 359-360.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Towards the optimal treatment strategy

T2 - 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)

AU - Molenaar, Pam

AU - Weir, Daniala

AU - Arnoldus, Edo P. J.

AU - Beenakker, Martijn

AU - van den Bos, Robert

AU - Bouma, Paul

AU - van Eijk, Jeroen

AU - Feenstra, Carola

AU - van Geel, Bjorn

AU - Heersema, Thea

AU - Hoitsma, E.

AU - Horvath, Katalin

AU - Killestein, Joep

AU - Kragt, Jolijn

AU - van Munster, Caspar

AU - Snoeijen, Angelique

AU - Wokke, Beatrijs

AU - Goettsch, Wim

AU - Strijbis, Eva

AU - de Beukelaar, Janet

AU - Kalkers, Nynke. F.

AU - Brigit, de Jong

PY - 2025/9

Y1 - 2025/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=d7dz6a2i7wiom976oc9ff2iqvdhv8k5x&SrcAuth=WosAPI&KeyUT=WOS:001603659901080&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1352-4585

VL - 31

SP - 359

EP - 360

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - S3

Y2 - 24 September 2025 through 26 September 2025

ER -

Towards the optimal treatment strategy: what we can learn from real-world drug utilization patterns in the first years following a relapsing-remitting multiple sclerosis diagnosis

Other files and links

Cite this